Treatment and Management of Acinetobacter Pneumonia: Lessons Learned from Recent World Event

Abstract

Acinetobacter pneumonia is a significant healthcare-associated infection that poses a considerable challenge to clinicians due to its multidrug-resistant nature. Recent world events, such as the COVID-19 pandemic, have highlighted the need for effective treatment and management strategies for Acinetobacter pneumonia. In this review, we discuss lessons learned from recent world events, particularly the COVID-19 pandemic, in the context of the treatment and management of Acinetobacter pneumonia. We performed an extensive literature review to uncover studies and information pertinent to the topic. The COVID-19 pandemic underscored the importance of infection control measures in healthcare settings, including proper hand hygiene, isolation protocols, and personal protective equipment use, to prevent the spread of multidrug-resistant pathogens like Acinetobacter . Additionally, the pandemic highlighted the crucial role of antimicrobial stewardship programs in optimizing antibiotic use and curbing the emergence of resistance. Advances in diagnostic techniques, such as rapid molecular testing, have also proven valuable in identifying Acinetobacter infections promptly. Furthermore, due to the limited availability of antibiotics for treating infections caused A. baumannii , alternative strategies are needed like the use of antimicrobial peptides, bacteriophages and their enzymes, nanoparticles, photodynamic and chelate therapy. Recent world events, particularly the COVID-19 pandemic, have provided valuable insights into the treatment and management of Acinetobacter pneumonia. These lessons emphasize the significance of infection control, antimicrobial stewardship, and early diagnostics in combating this challenging infection.

High-Loading-Dose Colistin with Nebulized Administration for Carbapenem-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients: A Retrospective Cohort Study

“…Carbapenem-resistant Acinetobacter baumannii (CRAB) have been associated with serious infections and become an important public health challenge worldwide [ 1 , 2 ]. CRAB infections have shown resistance to a wide range of antimicrobials, including carbapenems, which serve as a model for CRAB or pandrug-resistant (PDR) bacteria.…”

A Bibliometric Analysis of the Role and Research Trending of Bronchoalveolar Lavage in the Diagnosis and Treatment of Ventilator-Associated Pneumonia

“…Bronchoalveolar lavage (BAL), a technique employed to diagnose and treat respiratory diseases, has garnered widespread attention in recent years for the diagnosis and treatment of VAP [ 5 ]. BAL involves the instillation of a small amount of saline into the alveoli, followed by the retrieval of lavage fluid for analysis to obtain deep lung samples [ 6 ].…”